Octavian Therapeutics
PrivateLast Round
Early Funding
Mar 1, 2025
Est. Valuation
$72.57M
Total Funding Raised
$22.36M
Company Overview
Octavian Therapeutics is a biopharmaceutical company focused on developing innovative prescription medicines targeting the endocannabinoid system to treat chronic neuropathic pain and other debilitating conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Octavian Therapeutics Comparables
Compare Octavian Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MIRA Pharmaceuticals, Inc. | 78% | |
| BRC Therapeutics | 78% | |
| Centrexion Therapeutics | 78% | |
Octavian Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 1, 2025 | ||||
| IPO | May 21, 2021 | ||||
| Series A | Jun 28, 2018 | ||||
| Seed | Mar 17, 2017 |
Octavian Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Casa Verde Capital | Series A |
| Kingsley Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2021
$23.25M raised in IPO round.
- Jun 28, 2018
$10M round led by Casa Verde Capital.
Octavian Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Octavian Therapeutics's valuation, stock price, and market status.